Related Experiment Videos

Percutaneous transluminal angioplasty in Takayasu arteritis

M Khalilullah1, S Tyagi

  • 1Department of Cardiology, Govind Ballabh Pant Hospital, New Delhi, India.

Heart and Vessels. Supplement
|January 1, 1992
PubMed

Insights

Percutaneous transluminal balloon angioplasty (PTBA) effectively treated stenotic lesions in Takayasu arteritis patients. This minimally invasive procedure showed high success rates and sustained relief in aorta and renal arteries, improving blood flow.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Radiology
  • Vascular Surgery

Background:

  • Takayasu arteritis is a rare, chronic inflammatory disease affecting large arteries, primarily the aorta and its branches.
  • Vascular stenosis in Takayasu arteritis can lead to severe complications, including hypertension and organ ischemia.
  • Percutaneous transluminal balloon angioplasty (PTBA) is a potential treatment option for managing arterial stenosis in these patients.

Purpose of the Study:

  • To evaluate the efficacy and safety of PTBA in treating stenotic lesions caused by Takayasu arteritis.
  • To assess the immediate and long-term outcomes of PTBA in various affected arteries.

Main Methods:

  • Retrospective analysis of 87 patients with 111 stenotic lesions due to Takayasu arteritis.
  • PTBA performed on aorta, renal, subclavian, and common iliac arteries.
  • Hemodynamic and angiographic follow-up studies to assess restenosis and long-term patency.

Main Results:

  • Successful dilatation achieved in 94.3% of aortic lesions and 90.6% of renal artery lesions.
  • Significant reduction in pressure gradients and increase in luminal diameter post-PTBA.
  • Long-term follow-up demonstrated sustained relief of stenosis in most cases, with manageable restenosis rates.

Conclusions:

  • PTBA is a safe and effective treatment for arterial stenosis in Takayasu arteritis.
  • The procedure leads to significant hemodynamic improvement and maintains patency in the majority of treated lesions.
  • PTBA offers a valuable therapeutic option for patients with Takayasu arteritis-related vascular complications.

Related Concept Videos